Editorial: Studying novel immune signatures, targets, and drugs in hepatobiliary tumors: based on advanced

Zixue Xuan1,2, Jian Song3, Quanjun Yang4

  • 1Center for Clinical Pharmacy, Cancer Center, Department of Pharmacy, Zhejiang Provincial People's Hospital (Affiliated People's Hospital), Hangzhou Medical College, Hangzhou, Zhejiang, China.

Frontiers in Immunology
|November 29, 2023
PubMed
Abstract

No abstract available in PubMed .

Related Concept Videos